A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation
Clinical trial NCT04204473 · COMPLETED
Trial details
- NCT number
- NCT04204473
- Sponsor
- TYK Medicines, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-07
- Primary completion
- 2023-03-03
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.